RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation
Journal of Cancer · 2026-01-30 · 17 (3) · 483-506
DOI: 10.7150/jca.125407 ↗At a glance
Journal article in Journal of Cancer, published on 2026-01-30. Written by Ke Du and 9 co-authors. Institution: National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'…. Cited 1 times so far (Crossref). The full text is freely available in PubMed Central.
Topics: Onkologische Pflege
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
Author keywords
Authors and institutions
- National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Cite
APA
Du, K., Liang, X., Qin, B., Liu, Z., Liu, N., Li, P., Wang, Q., Qi, Y., Shi, E., & Li, K. (2026). RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer, 17(3), 483-506. https://doi.org/10.7150/jca.125407
Vancouver
Du K, Liang X, Qin B, Liu Z, Liu N, Li P, et al. RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation. Journal of Cancer. 2026;17(3):483-506. doi:10.7150/jca.125407
BibTeX
@article{Du2026,
author = {Du, Ke and Liang, Xiao and Qin, Bowen and Liu, Zitao and Liu, Nanbin and Li, Pincheng and Wang, Qian and Qi, Yajie and Shi, Enze and Li, Kun},
title = {RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {3},
pages = {483--506},
doi = {10.7150/jca.125407}
}
EUVIMED